Cagrilintide & Semaglutide in Overweight Adults (REDEFINE 1) NEJM Med Journal Club YouTube Efficacy and safety of co administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, Treat to target in weight management with semaglutide: Realworld evidence from an eHealth clinic Seier 2025 Diabetes, Obesity and Metabolism Wiley Online Library Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit